Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation.
暂无分享,去创建一个
D. Blaise | M. Mohty | P. Viens | N. Vey | C. Chabannon | H. de Lavallade | T. Prebet | A. Stoppa | C. Faucher | J. El-Cheikh | S. Furst | P. Ladaique | M. Ferrando
[1] J. Bussel,et al. Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. , 2009, Blood.
[2] F. Aversa,et al. Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD , 2009, Bone Marrow Transplantation.
[3] J. Bussel,et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.
[4] D. Blaise,et al. Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation. , 2007, Haematologica.
[5] M. Mohty,et al. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond , 2007, Leukemia.
[6] A. Soubani,et al. The major autopsy findings in adult patients after hematopoietic stem cell transplantation. , 2007, Annals of transplantation.
[7] P. Staber,et al. Severe thrombocytopenia due to host‐derived anti‐HPA‐1a after non‐myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: a case report , 2005, Vox sanguinis.
[8] B. Coller,et al. Evidence for megakaryocyte engraftment following reduced-intensity conditioning. , 2004, Experimental hematology.
[9] R. Bouabdallah,et al. Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level , 2004, Transfusion.
[10] D. Blaise,et al. Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors. , 2004, Blood.
[11] D. Olive,et al. Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen. , 2003, Experimental hematology.
[12] M. Flowers,et al. Chronic graft-versus-host disease. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[13] J. Bourhis,et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. , 2002, Blood.
[14] C. Voena,et al. Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer. , 2002, Blood.
[15] D. Blaise,et al. Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] G. Tjønnfjord,et al. A randomised study of allogeneic transplantation with stem cells from blood or bone marrow , 2000, Bone Marrow Transplantation.
[17] J. Bourhis,et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] A. Nagler,et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. , 1998, Blood.
[19] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .